Brochure
2026 Product Catalog
A complete portfolio of human iPSC-derived neurons, glial cells, and skeletal muscle produced via footprint-free Quick-Tissue™ differentiation technology, functionally validated and ready to use in 1 to 4 weeks.
Download Your Brochure
"*" indicates required fields
We respect your inbox. You can unsubscribe at any time. View our privacy policy.
Inside This Brochure
Review the full portfolio of human iPSC-derived cell types available from Ricoh Biosciences, including functional characterization data, recommended applications, SKUs, and differentiation specifications for each product.
- Nine functionally validated iPSC-derived cell types are available, including excitatory, cholinergic, dopaminergic, GABAergic, motor, and sensory neurons, plus microglia, astrocytes, and skeletal muscle, spanning glial, neuronal, and muscle lineages.
- All cell types are produced using Quick-Tissue™ transcription factor-based differentiation with Sendai virus or mRNA delivery, achieving functional cells in 1 week (neurons, microglia, skeletal muscle) or 4 weeks (astrocytes), with no genomic integration and zero genetic modifications.
- Each product includes functional validation data, recommended applications, available formats, and full product specifications to support experimental planning from the moment of thaw.
Related Resources
Explore related cell models, services, and protocols connected to this application.